Home/Filings/4/0001209191-21-043305
4//SEC Filing

Ways Kirk 4

Accession 0001209191-21-043305

CIK 0001683553other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 4:21 PM ET

Size

8.2 KB

Accession

0001209191-21-043305

Insider Transaction Report

Form 4
Period: 2021-06-23
Ways Douglas Kirk
DirectorInterim Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-23+20,00020,000 total
    Exercise: $10.55Exp: 2031-06-22Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the stock option vest over a three-year period commencing June 23, 2021, with 1/36th of the shares vesting on a monthly basis.

Issuer

SPRUCE BIOSCIENCES, INC.

CIK 0001683553

Entity typeother

Related Parties

1
  • filerCIK 0001869391

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:21 PM ET
Size
8.2 KB